Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 01, 2024
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
From CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
From CNBC.com News
CNBC Daily Open: Everyone's waiting for Nvidia
August 28, 2024
From CNBC.com News
CNBC Daily Open: Stocks up ahead of Nvidia earnings
August 27, 2024
From CNBC.com News
5 things to know before the stock market opens Tuesday
August 27, 2024
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
From CNBC.com News
CNBC Daily Open: A 'crazy' summer
August 21, 2024
From CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
From CNBC.com News
Wednesday's big stock stories: What's likely to move the market in the next trading session
August 20, 2024
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
From CNBC.com News
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
August 08, 2024
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free